The Vanguard Group 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-31 10:09 am Sale | 2024-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | The Vanguard Group | 8,200,903 4.800% | -239,827 (-2.84%) | Filing |
| 2024-11-12 5:59 pm Unchanged | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | The Vanguard Group | 8,440,730 5.000% | 0 (Unchanged) | Filing |
| 2024-11-04 2:15 pm Purchase | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | The Vanguard Group | 8,440,730 5.000% | 8,440,730 (New Position) | Filing |